Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo

Kidney International

Volumn 66, Issue 3, 2004, Pages 983-989

  Patel, Nimesh S A ^b   Sharples, Edward J ^b   Cuzzocrea, Salvatore ^b   Chatterjee, Prabal K ^b   Britti, Domenico ^b   Yaqoob, Muhammad M ^b   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

Erythropoietin; Kidney; Mouse; Reperfusion injury

Indexed keywords

ASPARTATE AMINOTRANSFERASE; MALONALDEHYDE; MYELOPEROXIDASE; RECOMBINANT ERYTHROPOIETIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOLOGY; HORMONAL THERAPY; IN VIVO STUDY; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; LIPID PEROXIDATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; SHAM FEEDING; UREA BLOOD LEVEL;

EID: 4344675279     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00847.x     Document Type: Article

References (25)

1. JELKMANN W: Erythropoietin: Structure, control of production, and function. Physiol Rev 72:449-489, 1992
2. SIREN AL, FRATELLI M, BRINES M, et al: Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98:4044-4049, 2001
3. AGNELLO D, BIGINI P, VILLA P, et al: Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 952:128-134, 2002
4. JUNK AK, MAMMIS A, SAVITZ SI, et al: Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 99:10659-10664, 2002
5. SQUADRITO F, ALTAVILLA D, SQUADRITO G, et al: Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 127:482-488, 1999
6. CALVILLO L, LATINI R, KAJSTURA J, et al: Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 100:4802-4806, 2003
7. PARSA CJ, MATSUMOTO A, KIM J, et al: A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112:999-1007, 2003
8. SHARPLES EJ, PATEL N, BROWN P, et al: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion injury by the inhibition of the caspase cascade and apoptosis. J Am Soc Nephrol 14:F-PO957, 2003
9. HEESCHEN C, AICHER A, LEHMANN R, et al: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346, 2003
10. ASSMUS B, SCHACHINGER V, TEUPE C, et al: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017, 2002
11. CHATTERJEE PK, PATEL NSA, SIVARAJAH A, et al: GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int 63:853-865, 2003
12. CODY J, DALY C, CAMPBELL M, et al: Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev CD003266, 2001
13. PALLER MS: The cell biology of reperfusion injury in the kidney. J Invest Med 42:632-639, 1994
14. SHERIDAN AM, BONVENTRE JV: Pathophysiology of ischemic acute renal failure. Contrib Nephrol 132:7-21, 2001
15. KRIBBEN A, EDELSTEIN CL, SCHRIER RW: Pathophysiology of acute renal failure. J Nephrol 12 (Suppl 2):S142-S151, 1999
16. PALLER MS: Pathophysiologic mechanisms of acute renal failure, in Mechanisms of Injury in Renal Disease and Toxicity, edited by Goldstein RS, Ann Arbor, CRC Press, 1994, pp 3-13
17. DRAGUN D, HOFF U, PARK JK, et al: Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 58:2166-2177, 2000
18. FERNANDEZ M, MEDINA A, SANTOS F, et al: Exacerbated inflammatory response induced by insulin-like growth factor I treatment in rats with ischemic acute renal failure. J Am Soc Nephrol 12:1900-1907, 2001
19. HUANG C, DAVIS G, JOHNS EJ: Study of the actions of human recombinant erythropoietin on rat renal haemodynamics. Clin Sci (Lond) 83:453-459, 1992
20. CAI Z, MANALO DJ, WEI G, et al: Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108:79-85, 2003
21. PRASS K, SCHARFF A, RUSCHER K, et al: Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34:1981-1986, 2003
22. RUSCHER K, FREYER D, KARSCH M, et al: Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: Evidence from an in vitro model. J Neurosci 22:10291-10301, 2002
23. YANG CW, LI C, JUNG JY, et al: Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 17:1754-1755, 2003
24. LIN F, CORDES K, LI L, et al: Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 14:1188-1199, 2003
25. BAHLMANN FH, DEGROOT K, DUCKERT T, et al: Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 64:1648-1652, 2003